Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-08-09 Sale(A) |
2021-12-07 4:30 pm |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO 10% Owner |
220,000 | $20.11 | $4,423,144 | 738,209 (Direct) |
View |
2021-09-16 Sale |
2021-09-20 4:01 pm |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
21,100 | $20.99 | $442,830 | 57,004 (Direct) |
View |
2021-08-09 Sale |
2021-08-11 5:15 pm |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO 10% Owner |
220,000 | $20.11 | $4,423,144 | 648,573 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-12-28 Tax Withholding |
2021-12-30 9:31 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
31,728 | $12.98 | 766,481 (Direct) |
View |
2021-12-30 Gift |
2021-12-30 9:31 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
20,000 | $0 | 766,481 (Direct) |
View |
2021-12-28 Tax Withholding |
2021-12-30 9:30 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Rabinowitz Michael Chief Commercial Officer |
9,532 | $12.98 | 90,468 (Direct) |
View |
2021-12-16 Gift |
2021-12-17 5:15 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
5,000 | $0 | 52,004 (Direct) |
View |
2021-12-03 Gift |
2021-12-07 5:15 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
20,000 | $0 | 818,209 (Direct) |
View |
2021-08-31 Option Award(A) |
2021-12-07 4:30 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
100,000 | $0 | 838,209 (Direct) |
View |
2021-07-04 Ownership |
2021-10-15 5:15 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Friedman Aviad Director |
22,191 | $0 | 0 (Indirect) |
View |
2021-09-01 Option Award |
2021-09-02 4:48 pm |
N/A 2031-09-01 |
ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer |
50,000 | $0 | 100,000 (Direct) |
View |
2021-08-31 Option Award |
2021-09-02 4:46 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer |
66,666 | $0 | 141,666 (Direct) |
View |
2021-08-31 Option Award |
2021-09-02 4:46 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua Chief Operating & BO |
33,333 | $0 | 103,333 (Direct) |
View |
2021-08-31 Option Award |
2021-09-02 4:44 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
10,000 | $0 | 78,104 (Direct) |
View |
2021-08-31 Option Award |
2021-09-02 4:43 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO |
100,000 | $0 | 748,573 (Direct) |
View |
2021-08-09 Exercise |
2021-08-11 5:15 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
56,773 | $7.77 | 68,104 (Direct) |
View |
2021-08-09 Exercise |
2021-08-11 5:15 pm |
2017-02-09 2027-02-09 |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
79,136 | $0 | 68,104 (Direct) |
View |
2021-08-09 Exercise |
2021-08-11 5:15 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
5,697 | $6.23 | 68,104 (Direct) |
View |
2021-08-09 Tax Withholding |
2021-08-11 5:15 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
26,093 | $21.09 | 68,104 (Direct) |
View |
2021-08-09 Exercise |
2021-08-11 5:15 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
6,666 | $4.8 | 68,104 (Direct) |
View |
2021-08-09 Exercise |
2021-08-11 5:15 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
10,000 | $4.17 | 68,104 (Direct) |
View |
2021-08-04 Option Award |
2021-08-06 4:01 pm |
N/A 2031-08-04 |
ORAMED PHARMACEUTICALS INC. | ORMP | Rabinowitz Michael Chief Commercial Officer |
100,000 | $0 | 200,000 (Direct) |
View |
2021-02-26 Other |
2021-03-02 4:12 pm |
N/A N/A |
ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director |
453,125 | $3.68 | 592,014 (Indirect) |
View |
2021-02-17 Option Award |
2021-02-17 4:21 pm |
N/A 2031-02-17 |
ORAMED PHARMACEUTICALS INC. | ORMP | RAKIN KEVIN Director |
15,000 | $0 | 15,000 (Direct) |
View |
2021-02-03 Option Award |
2021-02-08 5:31 pm |
N/A 2031-02-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2021-02-03 Option Award |
2021-02-08 5:30 pm |
N/A 2031-02-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO 10% Owner |
150,000 | $0 | 150,000 (Direct) |
View |
2021-02-03 Option Award |
2021-02-08 5:29 pm |
N/A 2031-02-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO, Business Officer |
50,000 | $0 | 50,000 (Direct) |
View |
2021-02-03 Option Award |
2021-02-08 5:29 pm |
N/A 2031-02-03 |
ORAMED PHARMACEUTICALS INC. | ORMP | Gabay Avraham CFO, Treasurer and Secretary |
40,000 | $0 | 40,000 (Direct) |
View |